Back to Screener

Financial Services

Safeguard Scientifics, Inc.(SFES)

Live Price

Offline

$0.49

+0.00% today

Window Change

+0.00%

Window

May 29, 2026 โ†’ Jun 18, 2026

Market Cap
$10.00M
Revenue Growth
0.0%
EPS Growth
-1.6%
Dividend Yield
595.7%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 15 bars ยท May 29, 2026 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Safeguard Scientifics, Inc. (SFES) is a Financial Services stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.49 and up 0.0% across the available one-year price window (May 29, 2026 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -1.6%, a dividend yield of 595.7%. What stands out right now is revenue 0.0%, EPS -1.6%, free cash flow +10.0% with operating margin 0.0% and ROIC -14.7%. The dividend matters to the case here, with a current yield around 595.7%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SFES price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

0.0% vs +3.4% peer median

Operating Margin

Below sector median

0.0% vs +4.7% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 8, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at 0.0% and EPS is at -1.6%, with operating margin around 0.0%.

Shareholder return is still part of the story

The stock is still offering a dividend yield around 595.7%, which matters if the thesis depends on income as much as growth.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SFES

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SFES Max Drawdown

-22.45%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SFES and SPY.

Calendar-year return history is still loading or unavailable.
Safeguard Scientifics, Inc. logo

Company Overview

Safeguard Scientifics, Inc.

Other OTC

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.

Leadership
Mark R. Dow
IPO Date
Mar 17, 1980
Employees
33
Street Address
150 North Radnor Chester Road
Mailing
Radnor, PA, 19087
Region
Radnor, PA, US
Reporting Currency
USD
Investor Line
610-293-0600
Last Updated
May 4, 2026
CIK: 0000086115ISIN: US7864493066
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
โ€”
Price/Book
0.8

Growth

Revenue
0.0%
EPS
-1.6%
Free Cash Flow
+10.0%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-53.4%
ROIC
-14.7%

Balance Sheet

Debt/Equity
0.05
Current Ratio
7.09

Earnings Reports

๐Ÿ“… Last reportedMay 8, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 8, 26
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 26
โ€”
Est -0.29
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 13, 26
โ€”
Est -0.33
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 14, 25
0.10
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 14, 25
0.07
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Apr 15, 25
-0.33
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 27, 25
-0.33
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 15, 24
-0.07
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 14, 24
-0.10
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
May 13, 24
-0.12
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 26, 24
-0.27
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 2, 23
0.06
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Jun 30, 23
-0.18
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 23
-0.22
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 22
-0.30
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 29, 22
-0.19
Est โ€”
โ€”
โ€”
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.